The Pharmaceutical segment of Johnson & Johnson invested $5.3 billion in 2012 on research & development. The Pharmaceutical segment’s broad portfolio focuses on unmet medical needs across several therapeutic areas: cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience & pain, and oncology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use.
By clicking on the link below,you will live www.jnj.com.The terms-of-use and privacy policies on other sites may differ from those on www.jnj.com.
